At least 50 percent of adults with active epilepsy are also living with other health conditions say experts at a leading epilepsy medical research charity.
Epilepsy Society has welcomed a Department of Health initiative to introduce better labeling on the packaging of the anti-epileptic drug sodium valproate, warning women and healthcare professionals of the risks associated with the medication.
Epilepsy Society has reminded people whose seizures are triggered by flashing lights to take extra care as the winter season of parties and celebrations begins. Epilepsy Society’s consultant neurologist Dr Fergus Rugg-Gunn talks about ways to minimise your risk if you have photosensitive epilepsy.
Epilepsy Society has stressed that anti-psychotic drugs should only ever be prescribed for people with epilepsy where essential. The charity's Medical Director Professor Ley Sander said this was particularly important when prescribing for those who also had learning difficulties.
Epilepsy Society has welcomed the findings of a new study which shows that the performance of the generic version of lamotrigine is equivalent to the original branded version of the the anti-epileptic medication.
Results of a Europe-wide review of the epilepsy drug valproate, known to cause birth defects, has resulted in the Government sending strengthened warnings to all prescribing doctors and pharmacists.